Da Silva L C, Madruga C L, Carrilho F J, Pinho J R, Saéz-Alquezar A, Santos C, Bassit L, Barreto C, Fonseca L E, Alves V A, Leitão R, Vianna R, Cardoso R A, França A V, Gayotto L C
Department of Gastroenterology, University of São Paulo School of Medicine, Brazil.
J Gastroenterol. 1996 Oct;31(5):696-701. doi: 10.1007/BF02347619.
We investigated the frequency of HBsAg clearance and the possible role of viral superinfection in a long-term follow-up of 184 patients with chronic hepatitis B (CHB). Our subjects were 184 patients with chronic hepatitis B and the follow-up was 12-216 months (mean 66.2 +/- 53.7 months). The investigative methods used were: immunoenzymatic assays for HBV, HCV, HDV, and HIV markers; polymerase chain reaction (PCR) for HBV DNA; and liver biopsy and immunoperoxidase. During the follow-up, 20 of the 184 patients cleared serum HBsAg. A comparison of patients with persistent HBsAg(group I) and of those who cleared this marker (group II) showed a significant difference in mortality (P = 0.002) between the two groups and a tendency to a more severe exacerbation (flare) in group II (P = 0.07). Antibodies to hepatitis C and D virus as well as antibodies to HIV were equally distributed in both groups. Thirteen patients (7.9%) from group I, but none from group II, subsequently developed hepatocellular carcinoma. These results suggest that the frequency of spontaneous clearance of HBsAg during chronic HBV infection is low. No determinant factor for the clearance was found, including the presence of liver cirrhosis. Serum HBV DNA was undetectable by PCR after clearance in 16 out of 17 patients.
我们对184例慢性乙型肝炎(CHB)患者进行了长期随访,调查了HBsAg清除的频率以及病毒重叠感染的可能作用。我们的研究对象为184例慢性乙型肝炎患者,随访时间为12 - 216个月(平均66.2±53.7个月)。所采用的研究方法包括:针对HBV、HCV、HDV和HIV标志物的免疫酶测定;针对HBV DNA的聚合酶链反应(PCR);以及肝活检和免疫过氧化物酶法。在随访期间,184例患者中有20例清除了血清HBsAg。对持续存在HBsAg的患者(I组)和清除该标志物的患者(II组)进行比较,结果显示两组之间在死亡率上存在显著差异(P = 0.002),且II组有更严重病情加重(发作)的趋势(P = 0.07)。丙型肝炎病毒和丁型肝炎病毒抗体以及HIV抗体在两组中的分布相同。I组有13例患者(7.9%)随后发生肝细胞癌,而II组无一例发生。这些结果表明,慢性HBV感染期间HBsAg自发清除的频率较低。未发现清除的决定性因素,包括肝硬化的存在。17例患者中有16例在清除后通过PCR检测不到血清HBV DNA。